¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proliferation phase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation
    Áõ½Ä
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
  • pseudosarcomatous proliferation
    °ÅÁþÀ°Á¾Áõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • anal-sadistic phase
    Ç×¹®°¡Çбâ
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • circadian-phase intervention
    ÇÏ·çÁÖ±âÀ§»óÁßÀç
  • colostral phase
    ÃÊÀ¯±â, ùÁ¥¼·Ãë±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    Áõ½Ä
  • luteal phase endometrial biopsy
    Ȳü±âÀڱ󻸷»ý°Ë
  • phase contrast
    À§»ó´ëÁ¶
  • luteal phase defect
    Ȳü±â°á¼Õ
  • phase difference
    À§»óÂ÷
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase
    »ó, ±â, À§»ó
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • latent phase
    ÀáÀç±â , Àẹ±â
  • plateau phase
    ÆíÆò±â, °íÁ¶±â
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • resolution phase
    ÇØ¼Ò±â
  • resting phase
    È޽ıâ
  • solid phase
    °íü»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation
    Áõ½Ä
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
  • pseudosarcomatous proliferation
    °ÅÁþÀ°Á¾¼ºÁõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • anal-sadistic phase
    Ç×¹®°¡Çбâ
  • phase advance
    À§»óÀüÁø
  • phase artifact
    À§»óÀΰø¹°
  • phase axis
    ˤȗ̈
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation phase
    Áõ½Ä±â(ñòãÖÑ¢).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation zone
    Áõ½ÄÃþ
  • reactive pseudosarcomatous proliferation
    ¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡­Ê£àõë¿ðþàõ)
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • DNA synthetic phase
    DNA ÇÕ¼º±â
  • Go phase
    Go±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation phase
    Áõ½Ä±â(ñòãÖÑ¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • atherosclerosis,intimal smooth muscle proliferation
    ³»¸·ÆòȰ±Ù Áõ½Ä(ҮدøÁüÀÐÉñòãÖ)
  • cell proliferation
    ¼¼Æ÷ Áõ½Ä
  • cell,proliferation
    Áõ½Ä(ñòãÖ)
  • lymphocyte proliferation
    ¸²ÇÁ±¸Áõ½Ä
  • massive periretinal proliferation<¿¾>=>PVR
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • nuclear proliferation =nucleosis
    ÇÙÁõ½Ä(ú·ñòãÖ).
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °¡¼º»óÇÇÁ¾¼º Áõ½Ä
  • pseudosarcomatous proliferation
    °¡¼ºÀ°Á¾¼º Áõ½Ä(Ê£àõë¿ðþàõ ñòãÖ)
  • reactive pseudosarcomatous proliferation
    ¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡­Ê£àõë¿ðþàõ)
  • zone of proliferation
    Áõ½ÄÃþ, Áõ½Ä´ë (ñòãÖÓá).
  • luteal phase progestational phase
    Ȳ(»ö)ü±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Proliferation zone
    Áõ½ÄÃþ
    [¿¾ ¿ë¾î] Áõ½Ä´ë
  • Luteal phase [Progestational phase]
    Ȳ(»ö)ü±â
    [¿¾ ¿ë¾î] Ȳü±â
  • Leptotene phase
    °¡´Â¼¶À¯±â
    [¿¾ ¿ë¾î] ¼¼»ç±â
  • Phase of cornification
    °¢Áú±â
    [¿¾ ¿ë¾î] °¢ÁúÈ­±â
  • Diplotene phase
    °ã¼¶À¯±â
    [¿¾ ¿ë¾î] ¹è»ç±â
  • Pachytene phase
    ±½Àº¼¶À¯±â
    [¿¾ ¿ë¾î] ÈÄ»ç±â
  • Ovogenetic phase
    ³­Àڹ߻ý±â
    [¿¾ ¿ë¾î] ³­Àڹ߻ý±â
  • Follicular phase
    ³­Æ÷±â
    [¿¾ ¿ë¾î] ³­Æ÷±â
  • Bilateral phase
    ´ëαâ
    [¿¾ ¿ë¾î] ¾çÃø»ó
  • Phase of desquamation
    ¹Ú¸®±â
    [¿¾ ¿ë¾î] ¹Ú¸®±â
  • Phase of incornification
    ºñ°¢Áú±â
    [¿¾ ¿ë¾î] ºñ°¢ÁúÈ­±â
  • Unequal phase
    ºñ´ëαâ
    [¿¾ ¿ë¾î] ºÎµî»ó
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
  • Lactiferous phase
    ¼öÀ¯±â
    [¿¾ ¿ë¾î] ¼öÀ¯±â
  • Synaptic phase
    ¿¬Á¢±â
    [¿¾ ¿ë¾î] ¿¬Á¢±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocytic phase
    ÀûÇ÷±¸³»¹ßÀ°±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aqueous phase separator centrifugation
    ¾×»ó ºÐ¸®Ã¼ ¿ø½ÉºÐ¸® (äûßÒ ÝÂ×îô÷ êÀãýÝÂ×î)
  • carboxylation phase
    Ä«¸£º¹½ÇÈ­(ûù)±â(Ñ¢)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • decline phase
    "°¨Åð±â(Êõ÷ÜÑ¢), (ÔÒ) death phase"
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • exponential phase
    Áö¼ö±â (ò¦â¦Ñ¢)
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
  • immobile phase
    °íÁ¤»ó(ͳïÒßÓ)
  • inductive phase
    À¯µµ±â(ë¯ÓôÑ¢)
  • lag phase
    Áöü½Ã±â(òÀôòãÁÑ¢)
  • lateral phase separation
    Ãø¸é»óºÐ¸®(ö°ØüßÀÝÂ×î)
  • log phase
    log ±â(Ñ¢)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
  • mobile phase
    À̵¿»ó(ì¹ÔÑßÈ)
  • negative phase
    °¨¼Ò±â(Êõá´Ñ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    Áõ½Ä, ¹ø½Ä
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • arterial phase
    µ¿¸Æ±â
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • equilibrium phase
    ÆòÇü±â
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • in phase
    µ¿À§»ó
  • in-phase image
    À§»ó³»¿µ»ó
  • intravoxel phase dispersion
    º¹¼¿³»À§»óÈ®»ê
  • out of phase
    Å»À§»óÀÇ
  • out of phase gradient echo image
    Å»À§»ó°æ»ç¿¡ÄÚ¿µ»ó
  • phase
    ȗ, ˤȗ
  • phase angle
    À§»ó°¢
  • phase artifact
    À§»óÀΰø¹°
  • phase axis
    ˤȗ̈
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
ILP inadequate luteal phase; insufficiency of luteal phase; interstitial laser photocoagulation; interst...
SPIA solid-phase immunoabsorption; solid-phase immunoassay
PIF   1) Proliferation Inhibitory Factor
  2) Prolactin release Inhibiting Factor...
ALEP atypical lymphoepithelioid cell proliferation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Phase I phase
S phase synthesis phase
LPT Lymphocyte Proliferation Test
LP Lymphocyte proliferation
MPP Massive periretinal proliferation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • proliferation phase
    Áõ½Ä±â
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone proliferation
    °ñ Áõ½Ä
  • pseudosarcomatous proliferation
    °¡¼º À°Á¾¼º Áõ½Ä
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
    ¹Ì»ý¹° ¹è¾ç ½Ã °©Àڱ⠼ºÀåÀÌ Áõ°¡ÇÏ´Â ½Ã±â.
  • acute phase protein
    ±Þ¼º±â ´Ü¹éÁú
    °¨¿°À̳ª Á¶Á÷ ¼Õ»óÀÌ ÀÖÀ» ¶§ Á¤»óº¸´Ù 2-100¹è Á¤µµ Áõ°¡ÇÏ´Â Ç÷Àå ´Ü¹éÁúÀ» ÃÑĪÇÏ¿© APP¶ó°í ÇÏ¸ç ¼±Ãµ¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
  • acute phase reaction
    ±Þ¼º±â ¹ÝÀÀ
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • anal-sadistic phase
    Ç×¹®-°¡Çбâ, Ç×¹®-°¡ÇÐ ½Ã±â
  • arousal phase
    ÀáÀ» ±ú´Â ½Ã±â
  • arterial phase
    µ¿¸Æ ±â
  • bacterial phase
    ¼¼±Õ »ó
    ¼¼±ÕÀÌ ´«¿¡ º¸ÀÌ´Â ¾ç»ó.
  • closing phase
    Æó±¸ ´Ü°è
  • dispersed phase
    ºÐ»ê »ó
  • equilibrium phase diagram
    ÆòÇü »óŵµ
    ÇÕ±ÝÀÇ Á¶¼º°ú ¿Âµµ°¡ ¹Ù²î¾îÁ³À» ¶§ÀÇ ÆòÇü »óÅ¿¡¼­ÀÇ »óÀÇ º¯È­¸¦ º¸ÀÎ ±×¸².
  • expiratory phase
    È£±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gingival proliferation Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells.
(12 Dec 1998)
regulatory cell proliferation kinase <enzyme> Involved in mitosis regulation; has characteristics of serine/threonine and tyrosine kinases; isolated from saccharomyces cerevisiae; genbank l08909
Registry number: EC 2.7.1.-
Synonym: rpk1 protein, rpk1 gene product
(26 Jun 1999)
cell proliferation <cell biology> Increase in cell number by division.
(26 Mar 1998)
proliferation <cell biology> The reproduction or multiplication of similar forms, especially of cells and morbid cysts.
Origin: L. Proles = offspring, ferre = to bear
(18 Nov 1997)
proliferation cyst A mother cyst containing daughter cyst's; a cyst with tumourous formation at one portion of the sac.
(05 Mar 2000)
proliferation therapy Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates.
(05 Mar 2000)
diffuse mesangial proliferation <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
acceleration phase <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes.
After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase).
(15 Jan 1998)
acute-phase protein <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor).
Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold.
Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability.
These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers.
See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity.
(25 Jun 1999)
acute-phase reaction <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms.
It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors.
(12 Jul 2000)
anal phase In psychoanalytic personality theory, the stage of psychosexual development, occurring when a child is between 1 and 3 years, during which activities, interests, and concerns are centreed around the anal zone.
(05 Mar 2000)
aqueous phase The water portion of a system consisting of two liquid phase's, one mainly water, the other a liquid immiscible with water (e.g., benzene, ether).
(05 Mar 2000)
blast phase Refers to advanced chronic myelogenous leukaemia. In this phase, the number of immature, abnormal white blood cells in the bone marrow and blood is extremely high. Also called blast crisis.
(12 Dec 1998)
g0 phase Phase of the cell cycle where cells exist in a quiescent state. These cells have unduplicated DNA, degraded RNA and protein, and low enzyme activity. The ability to switch between g0 and g1 (and vice versa) determines the post-embryonic cell proliferation rate and is defectively controlled in neoplastic cells.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    ºÐ¾Æ(ºÐ¿­) Áõ½Ä;°ÝÁõ;±ÞÁõ;È®»ên
  • color phase
    À¯Àü¿¡ ÀÇÇÑ Ã¼»ö º¯È­;°èÀý¿¡ µû¸¥ ¸ðÀÇÀÇ º¯È­»ö
  • phase
    º¯È­;¹ß´ÞÀÇ ´Ü°è;Çü¼¼;±¹¸é;¸é;»ó;À§»óÀ¸·Î ³ª´©´Ù
  • phase angle
    À§»ó°¢
  • phase contrast
    À§»óÂ÷
  • phase microscope
    À§»óÂ÷ Çö¹Ì°æ
  • phase modulation
    À§»ó º¯Á¶
  • phase zero
    (°èȹ µîÀÇ) Áغñ ´Ü°è;Á¦·Î ´Ü°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á